ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 84 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q2 2021. The put-call ratio across all filers is 1.06 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $1,840,000 | -29.1% | 346,500 | -28.0% | 0.31% | -75.4% |
| Q4 2020 | $2,594,000 | +77.2% | 481,284 | +162.3% | 1.24% | +763.9% |
| Q3 2020 | $1,464,000 | -41.7% | 183,480 | -0.8% | 0.14% | +4.3% |
| Q3 2018 | $2,509,000 | +164.1% | 185,000 | +131.2% | 0.14% | +130.0% |
| Q2 2018 | $950,000 | -79.7% | 80,000 | -80.8% | 0.06% | -88.1% |
| Q1 2018 | $4,677,000 | +7.9% | 416,457 | -35.8% | 0.50% | -36.7% |
| Q4 2017 | $4,333,000 | +33.7% | 648,645 | +63.9% | 0.80% | +435.6% |
| Q3 2017 | $3,242,000 | +437.6% | 395,824 | +691.6% | 0.15% | +52.0% |
| Q4 2015 | $603,000 | – | 50,000 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 12,025,999 | $66,263,000 | 2.30% |
| Abingworth LLP | 250,000 | $1,375,000 | 1.02% |
| Tekla Capital Management LLC | 1,466,368 | $8,080,000 | 0.31% |
| Rock Springs Capital Management LP | 875,000 | $4,821,000 | 0.28% |
| QVT Financial LP | 1,360,647 | $6,940,000 | 0.22% |
| Vident Investment Advisory, LLC | 232,641 | $1,282,000 | 0.13% |
| Hillhouse Capital Management | 1,190,476 | $6,560,000 | 0.13% |
| Orbimed Advisors | 1,914,660 | $10,550,000 | 0.12% |
| Granite Investment Partners, LLC | 195,571 | $1,078,000 | 0.07% |
| Monashee Investment Management LLC | 25,000 | $138,000 | 0.06% |